DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,244 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $15,095,771 | +1.9% | 60,424 | +1.8% | 0.32% | +0.6% |
Q1 2024 | $14,818,380 | +8.7% | 59,340 | +0.7% | 0.32% | -0.9% |
Q4 2023 | $13,630,791 | -7.6% | 58,921 | -0.9% | 0.32% | -15.0% |
Q3 2023 | $14,750,320 | +2.6% | 59,453 | -0.8% | 0.38% | +5.5% |
Q2 2023 | $14,381,040 | -4.1% | 59,921 | +0.8% | 0.36% | -10.4% |
Q1 2023 | $14,988,824 | -6.9% | 59,470 | -1.9% | 0.40% | -13.1% |
Q4 2022 | $16,092,961 | +8.5% | 60,632 | +5.6% | 0.46% | -13.6% |
Q3 2022 | $14,827,000 | +5.5% | 57,404 | +3.5% | 0.54% | +7.2% |
Q2 2022 | $14,057,000 | -13.7% | 55,449 | -0.2% | 0.50% | -2.9% |
Q1 2022 | $16,291,000 | -9.7% | 55,539 | +1.3% | 0.52% | -8.3% |
Q4 2021 | $18,039,000 | +13.5% | 54,827 | +5.0% | 0.56% | +0.5% |
Q3 2021 | $15,890,000 | +13.9% | 52,193 | +0.4% | 0.56% | -0.9% |
Q2 2021 | $13,952,000 | +22.6% | 51,987 | +2.7% | 0.56% | +9.9% |
Q1 2021 | $11,379,000 | +2.2% | 50,597 | +0.7% | 0.51% | -6.4% |
Q4 2020 | $11,136,000 | +3.0% | 50,222 | +0.1% | 0.55% | -6.5% |
Q3 2020 | $10,807,000 | +10.8% | 50,188 | -9.0% | 0.59% | +5.4% |
Q2 2020 | $9,750,000 | +32.1% | 55,137 | +3.4% | 0.56% | +9.2% |
Q1 2020 | $7,383,000 | -1.1% | 53,342 | +9.7% | 0.51% | +10.4% |
Q4 2019 | $7,464,000 | +26.3% | 48,632 | +18.9% | 0.46% | +9.0% |
Q3 2019 | $5,909,000 | +7.8% | 40,915 | +6.7% | 0.42% | +3.2% |
Q2 2019 | $5,481,000 | +19.1% | 38,344 | +10.0% | 0.41% | +10.8% |
Q1 2019 | $4,603,000 | +35.2% | 34,867 | +5.6% | 0.37% | +15.2% |
Q4 2018 | $3,404,000 | +2.7% | 33,014 | +8.2% | 0.32% | +15.8% |
Q3 2018 | $3,315,000 | +11.5% | 30,502 | +1.2% | 0.28% | -1.4% |
Q2 2018 | $2,973,000 | +2.9% | 30,127 | +2.1% | 0.28% | -3.8% |
Q1 2018 | $2,888,000 | +13.3% | 29,497 | +7.4% | 0.29% | +8.9% |
Q4 2017 | $2,550,000 | +2.5% | 27,463 | -5.3% | 0.27% | -15.7% |
Q3 2017 | $2,488,000 | +58.3% | 29,008 | +55.8% | 0.32% | +43.0% |
Q2 2017 | $1,572,000 | +15.8% | 18,620 | +17.4% | 0.22% | -16.8% |
Q1 2017 | $1,357,000 | +24.8% | 15,864 | +13.5% | 0.27% | +14.0% |
Q4 2016 | $1,087,000 | +8.6% | 13,972 | +11.5% | 0.24% | +4.4% |
Q3 2016 | $1,001,000 | -10.1% | 12,532 | +0.6% | 0.22% | -12.1% |
Q2 2016 | $1,114,000 | +10.5% | 12,463 | +17.3% | 0.26% | -1.2% |
Q1 2016 | $1,008,000 | +75.3% | 10,626 | +71.9% | 0.26% | +44.7% |
Q4 2015 | $575,000 | – | 6,183 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |